Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Capital Expenditures (2023)

Mangoceuticals' Capital Expenditures history spans 1 years, with the latest figure at $3519.0 for Q1 2023.

  • For Q1 2023, Capital Expenditures changed N/A year-over-year to $3519.0; the TTM value through Dec 2023 reached $3519.0, changed N/A, while the annual FY2023 figure was $3519.0, N/A changed from the prior year.
  • Capital Expenditures for Q1 2023 was $3519.0 at Mangoceuticals.
  • Across five years, Capital Expenditures topped out at $3519.0 in Q1 2023 and bottomed at $3519.0 in Q1 2023.